Utility of a Second Interim Maintenance Phase to Improve Outcomes for Pediatric Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group
Etan Orgel(Children's Hospital of Los Angeles), Mignon L. Loh(Seattle Children's Hospital), Brent L. Wood(University of Southern California), Eric Larsen(University of Massachusetts Chan Medical School), Stephen P. Hunger(Children's Hospital of Philadelphia), Elizabeth A. Raetz(NYU Langone Health), John A. Kairalla(BC Children's Hospital), David T. Teachey(Children's Hospital of Philadelphia), Anne Angiolillo(Children's National), Naomi Winick(The University of Texas Southwestern Medical Center), Leonard A. Mattano, Andrew J. Carroll(University of Alabama at Birmingham), Michael J. Burke(Children's Hospital of Wisconsin), Kelly W. Maloney(Children's Hospital Colorado), William L. Carroll(NYU Langone Health), Meenakshi Devidas(National Institutes of Health), Nyla A. Heerema(The Ohio State University), Wanda L. Salzer(Maine Medical Center), M Borowitz(Johns Hopkins University), Emily Hibbitts(University of Florida)
Cited by 0
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k